Rights and permissions
About this article
Cite this article
Enalapril has a favourable benefit-to-risk ratio compared with other first-line antihypertensives. Inpharma Wkly. 739, 21–22 (1990). https://doi.org/10.2165/00128413-199007390-00049
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199007390-00049